No, didn't notice. Thanks for the pointer. I was wrong on generic Lovenox and probably on generic Copaxone, as for both I didn't believe the FDA was/is willing to approve a complexed generics without clinical studies. Luckily as you know, at least the Lovenox saga had a good economic outcome for me :-)
Market Data 
Markets 
AI
